We are live on ! Find out more
HP

Hikari Power Portfolio holdings

AUM $855M
1-Year Est. Return 14.24%
This Fund
S&P 500
This Quarter Est. Return
+1.39%
1 Year Est. Return
+14.24%
3 Year Est. Return
+53.45%
5 Year Est. Return
+75.51%
10 Year Est. Return
+220.8%
AUM
$1.02B
AUM Growth
-$17.2M
Cap. Flow
-$20.2M
Cap. Flow %
-1.97%
Top 10 Hldgs %
72.97%
Holding
65
New
1
Increased
2
Reduced
9
Closed
1

Top Buys

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$231K
2
WAT icon
Waters Corp
WAT
+$69.1K
3
BN icon
Brookfield
BN
+$67.6K

Top Sells

Rank Stock Value
1
MMM icon
3M
MMM
+$14.4M
2
WFC icon
Wells Fargo
WFC
+$2.05M
3
NVO
Novo Nordisk
NVO
+$1.89M
4
AMGN icon
Amgen
AMGN
+$1.3M
5
WAB icon
Wabtec
WAB
+$334K

Sector Composition

Rank Sector Weight
1 Financials 50.33%
2 Healthcare 17.53%
3 Materials 7.92%
4 Energy 7.83%
5 Technology 4.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRU icon
51
Prudential Financial
PRU
$42.2B
$603K 0.06%
6,350
– –
IEX icon
52
IDEX
IEX
$17.5B
$564K 0.06%
2,710
– –
AVXL icon
53
Anavex Life Sciences
AVXL
$325M
$561K 0.05%
85,585
– –
BTI icon
54
British American Tobacco
BTI
$122B
$529K 0.05%
16,850
– –
BN icon
55
Brookfield
BN
$110B
$469K 0.05%
22,500
+3,000
+15% +$67.6K
VEEV icon
56
Veeva Systems
VEEV
$38.4B
$407K 0.04%
2,000
– –
VYM icon
57
Vanguard High Dividend Yield ETF
VYM
$83.8B
$251K 0.02%
2,430
– –
ELV icon
58
Elevance Health
ELV
$84.7B
$222K 0.02%
+510
New +$231K
ALPN
59
DELISTED
Alpine Immune Sciences Inc
ALPN
$142K 0.01%
12,445
– –
ALDX icon
60
Aldeyra Therapeutics
ALDX
$91.1M
$134K 0.01%
20,020
– –
CRVS icon
61
Corvus Pharmaceuticals
CRVS
$1.24B
$73K 0.01%
49,959
– –
OCUL icon
62
Ocular Therapeutix
OCUL
$2.14B
$53K 0.01%
17,000
– –
AKTX
63
Akari Therapeutics
AKTX
$13.5M
– –
-164
Closed -$22K
1 2
3

Similar funds

QIM
Quest Investment Management Lake Oswego, Oregon $857M AUM 21.67% 1-Year Est. Return
NOCM
Night Owl Capital Management Greenwich, Connecticut $858M AUM 31.41% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
EPIMS
Evelyn Partners Investment Management Services London $850M AUM 20.89% 1-Year Est. Return
BCM
Benchstone Capital Management New York $860M AUM 32.46% 1-Year Est. Return
PCM
Parsifal Capital Management Greenwich, Connecticut $849M AUM 28.52% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Hikari Power's Q3 2023 Portfolio in Review

As of Q3 2023, Hikari Power held 65 positions worth $1.02B, down 1.7% from $1.04B the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 3.1%. Hikari Power opened 1 new position and exited 1, leaving the 65-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 50% of assets, up from 49% a quarter earlier, followed by Healthcare and Materials.

  • Hikari Power's largest Q3 2023 buy was Elevance Health: 510 shares worth $222K.
  • Hikari Power added most to Waters Corp in Q3 2023, an estimated $69.1K increase.
  • Hikari Power's biggest Q3 2023 reduction was 3M, cutting an estimated $14.4M.
  • Hikari Power fully exited Akari Therapeutics in Q3 2023, selling an estimated $22K.
  • Hikari Power's ten largest holdings make up 73% of its $1.02B portfolio in Q3 2023.
  • Hikari Power opened 1 new position and closed 1 in Q3 2023.
  • Hikari Power's portfolio value fell 1.7% quarter-over-quarter to $1.02B.

Based on Hikari Power's 13F filing for Q3 2023, filed 26 Oct 2023.